XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Investments:    
Fixed maturity securities, available for sale, at fair value (amortized cost of $43,784,431 as of 2023 and $44,866,019 as of 2022; allowance for credit losses of $2,047 as of 2023 and $3,347 as of 2022) $ 39,555,624 $ 39,804,617 [1]
Mortgage loans, carrying value 7,199,225 6,949,027 [1]
Limited partnerships and limited liability companies (2023 and 2022 include $1,065,628 and $684,834 related to consolidated variable interest entities) 1,657,415 1,266,779 [1]
Derivative instruments 684,033 431,727 [1]
Other investments 1,157,162 1,817,085 [1]
Total investments 51,418,338 51,325,298 [1]
Cash and cash equivalents (2023 and 2022 include $39,016 and $27,235 related to consolidated variable interest entities) 2,777,852 1,919,669 [1]
Coinsurance deposits (net of allowance for credit losses of $5,334 as of 2023 and $8,737 as of 2022) 13,710,877 13,254,956 [1]
Market risk benefits 230,304 229,871 [1]
Accrued investment income (2023 and 2022 include $493 and $3,444 related to consolidated variable interest entities) 497,425 497,851 [1]
Deferred policy acquisition costs 2,772,175 2,773,643 [1]
Deferred sales inducements 2,044,349 2,045,683 [1]
Deferred income taxes 290,648 438,434 [1]
Income taxes recoverable 50,821 55,498 [1]
Other assets (2023 and 2022 include $19,349 and $10,690 related to consolidated variable interest entities) 702,937 642,696 [1]
Total assets 74,495,726 73,183,599 [1]
Liabilities:    
Policy benefit reserves 59,019,189 58,781,836 [1]
Market risk benefits 2,653,185 2,455,492 [1]
Other policy funds and contract claims 306,359 512,790 [1]
Notes and loan payable 790,413 792,073 [1]
Subordinated debentures 78,839 78,753 [1]
Funds withheld for reinsurance liabilities 6,984,409 6,577,426 [1]
Other liabilities (2023 and 2022 include $127,519 and $78,644 related to consolidated variable interest entities) 2,034,523 1,614,479 [1]
Total liabilities 71,866,917 70,812,849 [1]
Stockholders' equity:    
Common stock; par value $1 per share; 200,000,000 shares authorized; issued and outstanding: 2023 - 77,753,194 shares (excluding 31,809,876 treasury shares); 2022 - 84,810,255 shares (excluding 24,590,353 treasury shares) 77,753 84,810 [1]
Additional paid-in capital 1,045,453 1,325,316 [1]
Accumulated other comprehensive loss (3,036,429) (3,746,230) [1]
Retained earnings 4,518,680 4,685,593 [1]
Total stockholders' equity attributable to American Equity Investment Life Holding Company 2,605,485 2,349,517 [1]
Noncontrolling interests 23,324 21,233 [1]
Total stockholders' equity 2,628,809 2,370,750 [1]
Total liabilities and stockholders' equity 74,495,726 73,183,599 [1]
Depositary Shares, each representing a 1/1,000th interest in a share of 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A    
Stockholders' equity:    
Preferred stock 16 16 [1]
Depositary Shares, each representing a 1/1,000th interest in a share of 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B    
Stockholders' equity:    
Preferred stock 12 12 [1]
Variable Interest Entities    
Investments:    
Real estate investments related to consolidated variable interest entities 1,164,879 1,056,063 [1]
Limited partnerships and limited liability companies (2023 and 2022 include $1,065,628 and $684,834 related to consolidated variable interest entities) 1,065,628 684,834
Cash and cash equivalents (2023 and 2022 include $39,016 and $27,235 related to consolidated variable interest entities) 39,016 27,235
Accrued investment income (2023 and 2022 include $493 and $3,444 related to consolidated variable interest entities) 493 3,444
Other assets (2023 and 2022 include $19,349 and $10,690 related to consolidated variable interest entities) 19,349 10,690
Total assets 2,289,365 1,782,266
Liabilities:    
Other liabilities (2023 and 2022 include $127,519 and $78,644 related to consolidated variable interest entities) 127,519 78,644
Total liabilities $ 127,519 $ 78,644
[1] Certain prior period amounts have been recast. See Note 1 - Significant Accounting Policies for more information.